12/20
01:22 am
ipha
Innate Pharma to Participate in the 43rd Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Low
Report
Innate Pharma to Participate in the 43rd Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
12/20
01:00 am
ipha
Innate Pharma to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Low
Report
Innate Pharma to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
12/11
09:59 pm
ipha
3 Promising Penny Stocks With Market Caps Under US$300M [Yahoo! Finance]
Medium
Report
3 Promising Penny Stocks With Market Caps Under US$300M [Yahoo! Finance]
12/9
08:11 am
ipha
Innate Pharma S.A. (NASDAQ: IPHA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $11.50 price target on the stock.
Low
Report
Innate Pharma S.A. (NASDAQ: IPHA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $11.50 price target on the stock.
12/9
01:00 am
ipha
Innate Pharma Presents Lacutamab Improved Health-related Quality of Life Data at ASH 2024 From TELLOMAK Phase 2 Study in Patients With Cutaneous T Cell Lymphoma
High
Report
Innate Pharma Presents Lacutamab Improved Health-related Quality of Life Data at ASH 2024 From TELLOMAK Phase 2 Study in Patients With Cutaneous T Cell Lymphoma
12/6
01:00 am
ipha
Innate Pharma and the Institute for Follicular Lymphoma Innovation (IFLI) Announce up to $7.9M Investment From IFLI to Support IPH6501 Development in Follicular Lymphoma
Low
Report
Innate Pharma and the Institute for Follicular Lymphoma Innovation (IFLI) Announce up to $7.9M Investment From IFLI to Support IPH6501 Development in Follicular Lymphoma
12/3
01:00 am
ipha
Innate Pharma Highlights Abstracts Selected for the ASH Annual Meeting 2024
Medium
Report
Innate Pharma Highlights Abstracts Selected for the ASH Annual Meeting 2024
11/20
01:00 am
ipha
Innate Pharma Releases Its 2025 Financial Calendar
High
Report
Innate Pharma Releases Its 2025 Financial Calendar
11/19
01:05 am
ipha
Innate Pharma Announces Publication in Science Immunology Highlighting Innovative Next-generation ANKET® IPH6501 [Yahoo! Finance]
Low
Report
Innate Pharma Announces Publication in Science Immunology Highlighting Innovative Next-generation ANKET® IPH6501 [Yahoo! Finance]
11/19
01:00 am
ipha
Innate Pharma Announces Publication in Science Immunology Highlighting Innovative Next-generation ANKET® IPH6501
Low
Report
Innate Pharma Announces Publication in Science Immunology Highlighting Innovative Next-generation ANKET® IPH6501
11/13
03:35 am
ipha
Discover 3 Promising Penny Stocks With Over US$90M Market Cap [Yahoo! Finance]
Medium
Report
Discover 3 Promising Penny Stocks With Over US$90M Market Cap [Yahoo! Finance]
11/13
01:00 am
ipha
Innate Pharma Reports Third Quarter 2024 Business Update and Financial Results
Medium
Report
Innate Pharma Reports Third Quarter 2024 Business Update and Financial Results
11/12
08:33 am
ipha
Innate Pharma S.A. (NASDAQ: IPHA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $11.50 price target on the stock.
Low
Report
Innate Pharma S.A. (NASDAQ: IPHA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $11.50 price target on the stock.
11/8
01:00 am
ipha
Innate Pharma Highlights Data From Its Innovative Oncology Portfolio Selected for the SITC Annual Meeting 2024
Low
Report
Innate Pharma Highlights Data From Its Innovative Oncology Portfolio Selected for the SITC Annual Meeting 2024
11/7
01:00 am
ipha
Innate Pharma Announces Conference Call and Webcast for Third Quarter 2024 Results and Business Updates
Medium
Report
Innate Pharma Announces Conference Call and Webcast for Third Quarter 2024 Results and Business Updates
10/29
02:00 am
ipha
Innate Pharma Announces Its Participation in Upcoming Investor Conferences
Medium
Report
Innate Pharma Announces Its Participation in Upcoming Investor Conferences
10/14
01:00 am
ipha
Innate Pharma Appoints Jonathan Dickinson as New Chief Executive Officer and Chairman of the Executive Board
Low
Report
Innate Pharma Appoints Jonathan Dickinson as New Chief Executive Officer and Chairman of the Executive Board